HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)

Kaye obtained her Masters of Pharmacy degree from the University College London and has spent the better part of her career as a clinical pharmacist in a tertiary care hospital. Her professional interests are centred on HEOR and HTA work, in hopes of ultimately influencing cost-effective decisions for patient care.